The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
Do not exceed 8 doses per month
Based on your results, we develop a personalized treatment protocol that may include bioidentical hormone replacement, targeted supplementation, peptide therapeutics, IV nutrient therapy, dietary modifications, and lifestyle interventions
Two copper-specific rules: no copper supplements while you are on it, and no vitamin C serum or vitamin C tablet within two hours of an injection
Because the ratio is fixed at manufacture, a researcher working with GLOW is always working with all three compounds simultaneously and cannot isolate the contribution of any one of them